BACKGROUND: Bilirubin may confer cardiovascular protection because of its strong antioxidative properties. Both thyroid dysfunction and the diabetic state affect bilirubin metabolism. Here we tested whether low-normal thyroid function affects serum bilirubin among euthyroid subjects with and without type 2 diabetes mellitus (T2DM). METHODS: Serum total bilirubin, thyrotropin and free thyroxine (free T4), transaminases, insulin sensitivity (homeostasis model assessment), and lipids were measured in 74 T2DM and 82 nondiabetic subjects with thyrotropin and free T4 levels within the euthyroid range. RESULTS: Bilirubin was positively related to free T4 in T2DM subjects (r = 0.370, p < 0.001), but not in nondiabetic subjects (r = 0.047, p = 0.68). In age- and sex-adjusted multiple linear regression analysis, free T4 was found to interact positively with the presence of T2DM on serum bilirubin (interaction term: β = 0.251, p = 0.024). This interaction remained present after additional adjustment for alcohol intake, aspartate aminotransferase and insulin sensitivity (interaction term: β = 0.222, p = 0.043), or alternatively for cholesterol and triglycerides (interaction term: β = 0.203, p = 0.057). CONCLUSIONS: Lower free T4 levels within the euthyroid range confer decreased bilirubin in T2DM. Low-normal thyroid function could enhance atherosclerosis susceptibility in T2DM by decreasing serum bilirubin.
BACKGROUND:Bilirubin may confer cardiovascular protection because of its strong antioxidative properties. Both thyroid dysfunction and the diabetic state affect bilirubin metabolism. Here we tested whether low-normal thyroid function affects serum bilirubin among euthyroid subjects with and without type 2 diabetes mellitus (T2DM). METHODS: Serum total bilirubin, thyrotropin and free thyroxine (free T4), transaminases, insulin sensitivity (homeostasis model assessment), and lipids were measured in 74 T2DM and 82 nondiabetic subjects with thyrotropin and free T4 levels within the euthyroid range. RESULTS:Bilirubin was positively related to free T4 in T2DM subjects (r = 0.370, p < 0.001), but not in nondiabetic subjects (r = 0.047, p = 0.68). In age- and sex-adjusted multiple linear regression analysis, free T4 was found to interact positively with the presence of T2DM on serum bilirubin (interaction term: β = 0.251, p = 0.024). This interaction remained present after additional adjustment for alcohol intake, aspartate aminotransferase and insulin sensitivity (interaction term: β = 0.222, p = 0.043), or alternatively for cholesterol and triglycerides (interaction term: β = 0.203, p = 0.057). CONCLUSIONS: Lower free T4 levels within the euthyroid range confer decreased bilirubin in T2DM. Low-normal thyroid function could enhance atherosclerosis susceptibility in T2DM by decreasing serum bilirubin.
Authors: Douwe Dekker; Mirrin J Dorresteijn; Margot Pijnenburg; Suzanne Heemskerk; Anja Rasing-Hoogveld; David M Burger; Frank A D T G Wagener; Paul Smits Journal: Arterioscler Thromb Vasc Biol Date: 2010-11-18 Impact factor: 8.311
Authors: Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi Journal: Ann Intern Med Date: 2008-05-19 Impact factor: 25.391
Authors: Petronella E Deetman; Stephan J L Bakker; Arjan J Kwakernaak; Gerjan Navis; Robin P F Dullaart Journal: PLoS One Date: 2014-03-03 Impact factor: 3.240
Authors: Marta Borges-Canha; João Sérgio Neves; Fernando Mendonça; Maria Manuel Silva; Cláudia Costa; Pedro M Cabral; Vanessa Guerreiro; Rita Lourenço; Patrícia Meira; Daniela Salazar; Maria João Ferreira; Jorge Pedro; Ana Leite; Madalena Von-Hafe; Catarina Vale; Sara Viana; Ana Sande; Sandra Belo; Eva Lau; Paula Freitas; Davide Carvalho Journal: Front Endocrinol (Lausanne) Date: 2020-10-28 Impact factor: 5.555